including NOACs

0:19:02

DVT/PE Diagnosis and Management, Including NOACs - Marc Carrier MD

0:30:46

NOACs fact and fiction

0:06:14

Warfarin and NOACs to prevent clots in Atrial Fibrillation

0:31:07

Novel oral anticoagulants #NOACs about #Rivaroxaban #dabigatran #apixaban

0:12:02

EHJ Today - Comparison of NOACS

0:13:32

NOACs should replace warfarin in all patients with atrial fibrillation - Pro - J. Camm

0:15:39

Radcliffe Cardiology - NOAC RTD - Session 4

0:07:01

NCDR: Intro of NOACs Has Improved Overall Anticoagulation Rates

0:32:30

Dr. William W. Wilson Talk 1 on Novel Oral Anticoagulants

0:20:18

Patient Pulse: The Patient's Guide to DOAC Reversal

0:22:30

Anticoagulation Treatment - The key to managing VTE explained

0:27:51

Direct-Acting Oral Anticoagulants (DOACs) | MOA , Indications, Adverse Reactions, Contraindications

0:23:34

NOACs: Do They Solve or Create Problems? (Miguel A. Valderrábano, MD)

0:59:28

EHRA free webinar: Use of oral anticoagulants in AF patients undergoing cardioversion

0:20:36

Dr. William W. Wilson Talk 3 on Novel Oral Anticoagulants

0:06:14

EP11: Reversing Anticoagulants - Warfarin Vs. NOACs

0:54:07

Anticoagulation, Hemostasis, and Reversal in Neurosurgery by Dr. Christopher Loftus

0:54:58

New Oral Anticoagulants - Benefits and Risks

0:03:26

NOACs Explained: Top 10 tips & tricks for Usage, Safety, and Cognitive Health in AF Patients

0:15:28

J.H. Beer (Baden, CH): NOACS -- navigating between studies, guidelines and real life

0:11:21

Unchanging Principle: Why NOACs used to reduce stroke and bleeding risk for AF patients

0:14:42

Hematology in 10 min: Anticoagulation therapy for Venous Thromboembolism

0:17:58

Direct Oral Anticoagulants (DOAC): A review

0:56:18

The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI-EuroPCR 2022